Lineage Cell Therapeutics, Inc. (LCTX)
USD 0.44
(6.78%)
USD 0.44
(6.78%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | - USD | -100.0% |
| 2022 | 1.00 USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 1.00 USD | 0.0% |
| 2018 | 1.00 USD | 0.0% |
| 2017 | 1.00 USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 1000.00 USD | -99.62% |
| 2014 | 266.02 Thousand USD | 48.87% |
| 2013 | 178.69 Thousand USD | 223.04% |
| 2012 | 55.31 Thousand USD | 8.09% |
| 2011 | 51.17 Thousand USD | 12.54% |
| 2010 | 45.47 Thousand USD | 18.46% |
| 2009 | 38.38 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | -100.0% |
| 1997 | 100 Thousand USD | -50.0% |
| 1996 | 200 Thousand USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - USD | 0.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q2 | 1.00 USD | 0.0% |
| 2023 Q3 | - USD | -100.0% |
| 2023 FY | - USD | -100.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2022 Q3 | - USD | -100.0% |
| 2022 FY | 1.00 USD | 0.0% |
| 2022 Q2 | 1.00 USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q4 | 1.00 USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q1 | 1.00 USD | 0.0% |
| 2021 Q4 | - USD | -100.0% |
| 2021 Q3 | 1.00 USD | 0.0% |
| 2021 Q2 | - USD | -100.0% |
| 2020 FY | - USD | -100.0% |
| 2020 Q3 | 1.00 USD | 0.0% |
| 2020 Q2 | - USD | -100.0% |
| 2020 Q1 | 1.00 USD | 0.0% |
| 2020 Q4 | - USD | -100.0% |
| 2019 Q3 | - USD | -100.0% |
| 2019 Q4 | 1.00 USD | 0.0% |
| 2019 Q2 | 1.00 USD | 0.0% |
| 2019 FY | 1.00 USD | 0.0% |
| 2019 Q1 | 1.00 USD | 0.0% |
| 2018 Q2 | 1.00 USD | 0.0% |
| 2018 Q4 | 1.00 USD | 0.0% |
| 2018 Q3 | - USD | -100.0% |
| 2018 Q1 | 1.00 USD | 0.0% |
| 2018 FY | 1.00 USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | 5.1 Million USD | 0.0% |
| 2017 Q3 | - USD | -100.0% |
| 2017 Q4 | 1.00 USD | 0.0% |
| 2017 FY | 1.00 USD | 0.0% |
| 2016 Q2 | 1.00 USD | 0.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q4 | 1000.00 USD | -99.62% |
| 2015 FY | 1000.00 USD | -99.62% |
| 2015 Q1 | 299.3 Thousand USD | 12.51% |
| 2015 Q2 | 297 Thousand USD | -0.77% |
| 2015 Q3 | 260 Thousand USD | -12.46% |
| 2014 Q3 | 253.56 Thousand USD | -1.69% |
| 2014 FY | 266.02 Thousand USD | 48.87% |
| 2014 Q2 | 257.92 Thousand USD | 9.02% |
| 2014 Q1 | 236.58 Thousand USD | 32.4% |
| 2014 Q4 | 266.02 Thousand USD | 4.91% |
| 2013 Q4 | 178.69 Thousand USD | 192.31% |
| 2013 Q1 | 52.33 Thousand USD | -5.39% |
| 2013 Q2 | 64.74 Thousand USD | 23.71% |
| 2013 FY | 178.69 Thousand USD | 223.04% |
| 2013 Q3 | 61.13 Thousand USD | -5.58% |
| 2012 Q2 | 55.01 Thousand USD | 0.28% |
| 2012 Q4 | 55.31 Thousand USD | -2.9% |
| 2012 Q1 | 54.86 Thousand USD | 7.21% |
| 2012 FY | 55.31 Thousand USD | 8.09% |
| 2012 Q3 | 56.96 Thousand USD | 3.54% |
| 2011 FY | 51.17 Thousand USD | 12.54% |
| 2011 Q3 | 61.11 Thousand USD | 7.52% |
| 2011 Q4 | 51.17 Thousand USD | -16.27% |
| 2011 Q1 | 70.66 Thousand USD | 55.4% |
| 2011 Q2 | 56.84 Thousand USD | -19.55% |
| 2010 Q1 | 56.58 Thousand USD | 47.41% |
| 2010 FY | 45.47 Thousand USD | 18.46% |
| 2010 Q4 | 45.47 Thousand USD | -8.1% |
| 2010 Q3 | 49.47 Thousand USD | 0.0% |
| 2010 Q2 | 49.47 Thousand USD | -12.56% |
| 2009 Q4 | 38.38 Thousand USD | 0.0% |
| 2009 FY | 38.38 Thousand USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 FY | - USD | -100.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 FY | 100 Thousand USD | -50.0% |
| 1997 Q1 | 200 Thousand USD | 0.0% |
| 1997 Q2 | 100 Thousand USD | -50.0% |
| 1996 Q3 | 200 Thousand USD | 0.0% |
| 1996 FY | 200 Thousand USD | 0.0% |
| 1996 Q4 | 200 Thousand USD | 0.0% |
| 1996 Q2 | 200 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -1.18 Million USD | 100.0% |
| Ampio Pharmaceuticals, Inc. | 1.00 USD | 100.0% |
| Armata Pharmaceuticals, Inc. | - USD | NaN% |
| Actinium Pharmaceuticals, Inc. | - USD | NaN% |
| Azitra, Inc. | -215.21 Thousand USD | 100.0% |
| Can-Fite BioPharma Ltd. | - USD | NaN% |
| Chromocell Therapeutics Corporation | - USD | NaN% |
| Calidi Biotherapeutics, Inc. | - USD | NaN% |
| CEL-SCI Corporation | 2.24 Million USD | 100.0% |
| iBio, Inc. | - USD | NaN% |
| MAIA Biotechnology, Inc. | - USD | NaN% |
| Matinas BioPharma Holdings, Inc. | - USD | NaN% |
| Navidea Biopharmaceuticals, Inc. | 427.34 Thousand USD | 100.0% |
| NovaBay Pharmaceuticals, Inc. | 2.87 Million USD | 100.0% |
| NanoViricides, Inc. | - USD | NaN% |
| Oragenics, Inc. | - USD | NaN% |
| BiomX Inc. | - USD | NaN% |
| BiomX Inc. | - USD | NaN% |
| Protalix BioTherapeutics, Inc. | 19.04 Million USD | 100.0% |
| Palatin Technologies, Inc. | - USD | NaN% |
| Scorpius Holdings, Inc. | 909.15 Thousand USD | 100.0% |
| Theriva Biologics, Inc. | - USD | NaN% |